journal

Annals of Internal Medicine

journal
https://read.qxmd.com/read/31683316/narrowing-vaccination-exemption-laws-lessons-from-california-and-beyond
#1
Michelle M Mello
No abstract text is available yet for this article.
November 5, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31683314/cost-effectiveness-analysis-of-lung-cancer-screening-in-the-united-states-a-comparative-modeling-study
#2
Steven D Criss, Pianpian Cao, Mehrad Bastani, Kevin Ten Haaf, Yufan Chen, Deirdre F Sheehan, Erik F Blom, Iakovos Toumazis, Jihyoun Jeon, Harry J de Koning, Sylvia K Plevritis, Rafael Meza, Chung Yin Kong
Background: Recommendations vary regarding the maximum age at which to stop lung cancer screening: 80 years according to the U.S. Preventive Services Task Force (USPSTF), 77 years according to the Centers for Medicare & Medicaid Services (CMS), and 74 years according to the National Lung Screening Trial (NLST). Objective: To compare the cost-effectiveness of different stopping ages for lung cancer screening. Design: By using shared inputs for smoking behavior, costs, and quality of life, 4 independently developed microsimulation models evaluated the health and cost outcomes of annual lung cancer screening with low-dose computed tomography (LDCT)...
November 5, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31683313/assessment-of-exemptions-from-vaccination-in-california-2015-to-2027
#3
Paul L Delamater, Alison M Buttenheim, Nicola P Klein, Salini Mohanty, Daniel A Salmon, Saad B Omer
No abstract text is available yet for this article.
November 5, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31683278/incidence-of-bloodstream-infections-length-of-hospital-stay-and-survival-in-patients-with-recurrent-clostridioides-difficile-infection-treated-with-fecal-microbiota-transplantation-or-antibiotics-a-prospective-cohort-study
#4
Gianluca Ianiro, Rita Murri, Giusi Desirè Sciumè, Michele Impagnatiello, Luca Masucci, Alexander C Ford, Graham R Law, Herbert Tilg, Maurizio Sanguinetti, Roberto Cauda, Antonio Gasbarrini, Massimo Fantoni, Giovanni Cammarota
Background: Clostridioides difficile infection (CDI) is a risk factor for bloodstream infection (BSI). Fecal microbiota transplantation (FMT) is more effective than antibiotics in treating recurrent CDI, but its efficacy in preventing CDI-related BSI is uncertain. Objective: To assess incidence of primary BSI in patients with recurrent CDI treated with FMT versus antibiotics. Design: Prospective cohort study. Patients treated with FMT and those treated with antibiotics were matched on propensity score...
November 5, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31683277/comparative-modeling-to-inform-health-policy-decisions-a-step-forward
#5
David D Kim, Peter J Neumann
No abstract text is available yet for this article.
November 5, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31658472/the-cost-effectiveness-of-cognitive-behavioral-therapy-versus-second-generation-antidepressants-for-initial-treatment-of-major-depressive-disorder-in-the-united-states-a-decision-analytic-model
#6
Eric L Ross, Sandeep Vijan, Erin M Miller, Marcia Valenstein, Kara Zivin
Background: Most guidelines for major depressive disorder recommend initial treatment with either a second-generation antidepressant (SGA) or cognitive behavioral therapy (CBT). Although most trials suggest that these treatments have similar efficacy, their health economic implications are uncertain. Objective: To quantify the cost-effectiveness of CBT versus SGA for initial treatment of depression. Design: Decision analytic model. Data Sources: Relative effectiveness data from a meta-analysis of randomized controlled trials; additional clinical and economic data from other publications...
October 29, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31658471/a-veteran-centric-model-of-care-crossing-the-cultural-divide
#7
Edward P Manning
No abstract text is available yet for this article.
October 29, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31658470/the-majority-subsidy
#8
Roy C Ziegelstein, Deidra C Crews
No abstract text is available yet for this article.
October 29, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31658469/geographic-variation-in-prevalence-of-adult-obesity-in-china-results-from-the-2013-2014-national-chronic-disease-and-risk-factor-surveillance
#9
Xiao Zhang, Mei Zhang, Zhenping Zhao, Zhengjing Huang, Qian Deng, Yichong Li, An Pan, Chun Li, Zhihua Chen, Maigeng Zhou, Chao Yu, Alfred Stein, Peng Jia, Limin Wang
No abstract text is available yet for this article.
October 29, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31658468/universal-access-to-cognitive-behavioral-therapy-and-antidepressants-is-necessary-for-all-patients-with-major-depressive-disorder
#10
Mark Sinyor
No abstract text is available yet for this article.
October 29, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31634918/international-consensus-guidelines-for-nonvariceal-gastrointestinal-bleeding-a-step-forward
#11
Angel Lanas
No abstract text is available yet for this article.
October 22, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31634917/management-of-nonvariceal-upper-gastrointestinal-bleeding-guideline-recommendations-from-the-international-consensus-group
#12
Alan N Barkun, Majid Almadi, Ernst J Kuipers, Loren Laine, Joseph Sung, Frances Tse, Grigorios I Leontiadis, Neena S Abraham, Xavier Calvet, Francis K L Chan, James Douketis, Robert Enns, Ian M Gralnek, Vipul Jairath, Dennis Jensen, James Lau, Gregory Y H Lip, Romaric Loffroy, Fauze Maluf-Filho, Andrew C Meltzer, Nageshwar Reddy, John R Saltzman, John K Marshall, Marc Bardou
Description: This update of the 2010 International Consensus Recommendations on the Management of Patients With Nonvariceal Upper Gastrointestinal Bleeding (UGIB) refines previous important statements and presents new clinically relevant recommendations. Methods: An international multidisciplinary group of experts developed the recommendations. Data sources included evidence summarized in previous recommendations, as well as systematic reviews and trials identified from a series of literature searches of several electronic bibliographic databases from inception to April 2018...
October 22, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31634915/fatal-lyme-carditis-in-new-england-two-case-reports
#13
Grace E Marx, Jillian Leikauskas, Katherine Lindstrom, Erin Mann, Sarah Reagan-Steiner, Eduard Matkovic, Jennifer S Read, Patsy Kelso, Natalie A Kwit, Alison F Hinckley, Mark A Levine, Catherine Brown
No abstract text is available yet for this article.
October 22, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31634914/life-gained-based-versus-risk-based-selection-of-smokers-for-lung-cancer-screening
#14
Li C Cheung, Christine D Berg, Philip E Castle, Hormuzd A Katki, Anil K Chaturvedi
Background: Although risk-based selection of ever-smokers for screening could prevent more lung cancer deaths than screening according to the U.S. Preventive Services Task Force (USPSTF) guidelines, it preferentially selects older ever-smokers with shorter life expectancies due to comorbidities. Objective: To compare selection of ever-smokers for screening based on gains in life expectancy versus lung cancer risk. Design: Cohort analyses and model-based projections...
October 22, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31634912/using-risk-models-to-make-lung-cancer-screening-decisions-evidence-based-and-getting-better
#15
Tanner J Caverly, Rafael Meza
No abstract text is available yet for this article.
October 22, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31634909/cases-in-precision-medicine-the-role-of-tumor-and-germline-genetic-testing-in-breast-cancer-management
#16
Jonah Tischler, Katherine D Crew, Wendy K Chung
Personalization of care through precision medicine and, more specifically, genetic testing is altering the treatment of breast cancer. Genetic testing is used in germline and tumor testing, with each providing distinct data to guide management. Germline testing supports more accurate risk evaluation to inform screening and risk-reducing medical and surgical strategies. Tumor testing can inform cancer recurrence risk assessment and cancer treatment options. This article reviews how genetic testing informs treatment and potential risks for a patient with breast cancer and her family...
October 22, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31634908/annals-graphic-medicine-ppis-for-happily-ever-after
#17
Annie Zhu, Chuck Resnick, Jeremy Rezmovitz
No abstract text is available yet for this article.
October 22, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31610579/rivaroxaban-versus-vitamin-k-antagonist-in-antiphospholipid-syndrome
#18
(no author information available yet)
No abstract text is available yet for this article.
October 15, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31610550/cases-in-precision-medicine-a-personalized-approach-to-stroke-and-cardiovascular-risk-assessment-in-women
#19
Natalie A Bello, Eliza C Miller, Kirsten Lawrence Cleary, Ronald Wapner
Cardiovascular disease is the leading cause of death among women in the United States, and stroke is third. This article uses a case scenario to examine female sex-specific cardiovascular risk factors across the lifespan and describes a precision medicine-based approach to risk factor modification and primary prevention. It also presents recent updates to the role of genetic testing and polygenic risk scores for the prediction of stroke and cardiovascular disease.
October 15, 2019: Annals of Internal Medicine
https://read.qxmd.com/read/31610549/rivaroxaban-versus-vitamin-k-antagonist-in-antiphospholipid-syndrome-a-randomized-noninferiority-trial
#20
Josep Ordi-Ros, Luis Sáez-Comet, Mercedes Pérez-Conesa, Xavier Vidal, Antoni Riera-Mestre, Antoni Castro-Salomó, Jordi Cuquet-Pedragosa, Vera Ortiz-Santamaria, Montserrat Mauri-Plana, Cristina Solé, Josefina Cortés-Hernández
Background: The potential role of new oral anticoagulants in antiphospholipid antibody syndrome (APS) remains uncertain. Objective: To determine whether rivaroxaban is noninferior to dose-adjusted vitamin K antagonists (VKAs) for thrombotic APS. Design: 3-year, open-label, randomized noninferiority trial. (EU Clinical Trials Register: EUDRA [European Union Drug Regulatory Authorities] code 2010-019764-36). Setting: 6 university hospitals in Spain...
October 15, 2019: Annals of Internal Medicine
journal
journal
20032
1
2
Fetch more papers »
Fetching more papers... Fetching...
Read by QxMD. Sign in or create an account to discover new knowledge that matter to you.
Remove bar
Read by QxMD icon Read
×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"